Search research articles
Contact Us
Filters
Showing results (1-10 of 46) with videos related to
Page
of 5
Sort By:
Journal of Hepatology
|
December 12, 2022
Reply to: "Factor VIII as a potential predictor of recurrent thrombosis in patients with non-cirrhotic portal vein thrombosis"
Anna Baiges, Joan Carles Reverter, Joan Carles García Pagán
Medicina Clinica
|
January 29, 2008
[Bilateral suprarenal hematoma in a 46-year-old male]
Mónica Rodríguez Carballeira, Carmen de Juan, Joan Carles Reverter
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
November 5, 2005
No impact of factor IX Ala-10 mutations in acenocoumarol-treated southern Europeans
Dolors Tàssies, Joan Monteagudo, Santiago Maragall, et al.
Analytica Chimica Acta
|
June 10, 2018
Enzyme-linked immunosorbent assays for therapeutic drug monitoring coumarin oral anticoagulants in plasma
J-Pablo Salvador, Dolors Tassies, Joan-Carles Reverter, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
October 17, 2006
Catastrophic antiphospholipid syndrome: proposed guidelines for diagnosis and treatment
Ronald A Asherson, Gerard Espinosa, Ricard Cervera, et al.
Clinical and Experimental Rheumatology
|
July 29, 2014
Endogenous thrombin potential in Behçet's disease: relationship with thrombosis and anticoagulant therapy
Juan-Carlos Mejía, Gerard Espinosa, Dolors Tàssies, et al.
The Israel Medical Association Journal : IMAJ
|
August 20, 2002
Vascular involvement in Behçet's disease
Gerard Espinosa, Ricard Cervera, Joan-Carles Reverter, et al.
Haematologica
|
November 5, 2002
Pharmacogenetics of acenocoumarol: cytochrome P450 CYP2C9 polymorphisms influence dose requirements and stability of anticoagulation
Dolors Tàssies, Carolina Freire, Josefina Pijoan, et al.
Rheumatology (Oxford, England)
|
November 26, 2020
Comment on: EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies
Gilberto Pires da Rosa, Paulo Bettencourt, Ester Ferreira, et al.
International Journal of Cardiology
|
January 29, 2009
Safety issues of adjunctive clopidogrel in patients discharged after percutaneous coronary intervention with stent placement and requiring oral anticoagulation
Eduard Guasch, Alessandro Sionis, Joan Carles Reverter, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 46) with videos related to
Sort By:
Page
of 5
Journal of Hepatology
|
December 12, 2022
Reply to: "Factor VIII as a potential predictor of recurrent thrombosis in patients with non-cirrhotic portal vein thrombosis"
Anna Baiges, Joan Carles Reverter, Joan Carles García Pagán
Medicina Clinica
|
January 29, 2008
[Bilateral suprarenal hematoma in a 46-year-old male]
Mónica Rodríguez Carballeira, Carmen de Juan, Joan Carles Reverter
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
November 5, 2005
No impact of factor IX Ala-10 mutations in acenocoumarol-treated southern Europeans
Dolors Tàssies, Joan Monteagudo, Santiago Maragall, et al.
Analytica Chimica Acta
|
June 10, 2018
Enzyme-linked immunosorbent assays for therapeutic drug monitoring coumarin oral anticoagulants in plasma
J-Pablo Salvador, Dolors Tassies, Joan-Carles Reverter, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
October 17, 2006
Catastrophic antiphospholipid syndrome: proposed guidelines for diagnosis and treatment
Ronald A Asherson, Gerard Espinosa, Ricard Cervera, et al.
Clinical and Experimental Rheumatology
|
July 29, 2014
Endogenous thrombin potential in Behçet's disease: relationship with thrombosis and anticoagulant therapy
Juan-Carlos Mejía, Gerard Espinosa, Dolors Tàssies, et al.
The Israel Medical Association Journal : IMAJ
|
August 20, 2002
Vascular involvement in Behçet's disease
Gerard Espinosa, Ricard Cervera, Joan-Carles Reverter, et al.
Haematologica
|
November 5, 2002
Pharmacogenetics of acenocoumarol: cytochrome P450 CYP2C9 polymorphisms influence dose requirements and stability of anticoagulation
Dolors Tàssies, Carolina Freire, Josefina Pijoan, et al.
Rheumatology (Oxford, England)
|
November 26, 2020
Comment on: EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies
Gilberto Pires da Rosa, Paulo Bettencourt, Ester Ferreira, et al.
International Journal of Cardiology
|
January 29, 2009
Safety issues of adjunctive clopidogrel in patients discharged after percutaneous coronary intervention with stent placement and requiring oral anticoagulation
Eduard Guasch, Alessandro Sionis, Joan Carles Reverter, et al.
Page
of 5